FDA authorizes Johnson & Johnson COVID-19 vaccine’s emergency use; CDC concurs

The Food and Drug Administration Friday granted an emergency use authorization for Johnson & Johnson’s single-dose COVID-19 vaccine. Following the EUA’s issuance, the Centers for Disease Control and Prevention accepted the recommendation of its own Advisory Committee on Immunization Practices to give its own approval.

The vaccine is approved for patients 18 years old and older and began shipping this morning; Johnson & Johnson expects to supply 20 million doses by the end of March.